Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.710
-0.060 (-3.39%)
At close: Feb 21, 2025, 4:00 PM
1.670
-0.040 (-2.34%)
After-hours: Feb 21, 2025, 7:53 PM EST
Chemomab Therapeutics Employees
Chemomab Therapeutics had 20 employees as of December 31, 2021.
Employees
20
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$719,950
Market Cap
32.24M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
CMMB News
- 3 days ago - Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns with FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug (CM-101) in Primary Sclerosing Cholangitis - GlobeNewsWire
- 2 months ago - Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit - GlobeNewsWire
- 3 months ago - Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab's CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis - GlobeNewsWire
- 6 months ago - Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update - GlobeNewsWire
- 7 months ago - Chemomab Therapeutics Announces Closing of $10 Million Private Placement - GlobeNewsWire
- 7 months ago - Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 7 months ago - Chemomab Therapeutics Announces $10 Million Private Placement - GlobeNewsWire